Cart
sales@molnova.com
WAY-647802
CAS No. 852225-20-8
WAY-647802( —— )
Catalog No. M28995 CAS No. 852225-20-8
WAY-647802 is a CDK inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 114 | Get Quote |
|
| 10MG | 167 | Get Quote |
|
| 25MG | 267 | Get Quote |
|
| 50MG | 413 | Get Quote |
|
| 100MG | 609 | Get Quote |
|
| 500MG | 1287 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameWAY-647802
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-647802 is a CDK inhibitor.
-
DescriptionWAY-647802 is a CDK inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorEzh2 (wild-type)| EZH2 (Y641F)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number852225-20-8
-
Formula Weight250.258
-
Molecular FormulaC11H14N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=O)N1CCN(CC1)c1ccc(nc1)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhou B, et al. Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas. J Med Chem. 2021 Oct 28;64(20):15170-15188.
molnova catalog
related products
-
BI-1347
BI-1347 is a potent, selective inhibitor of CDK8/cyclinC with IC50 of 1 nM。
-
CDK inhibitor E9
CDK inhibitor E9 is a novel CDK inhibitor that can overcomes ABC-mediated resistance of THZ1, functions as a potent, non-covalent inhibitor of CDK9 and a covalent inhibitor of CDK12.
-
YKL-1-116
YKL-1-116 is a potent, selective and covalent inhibitor of CDK7 that does not inhibit other CDKs; synergizes with 5-FU or nutlin-3 to kill HCT116 cells.
